Derivative poison pills could be invalid

August 05 2008

Despite recent reports, US companies will not be rushing to change their shareholder rights plans in the wake of the CSX case. The poison pills would punish the wrong parties and could be invalid

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Banking Structured finance and Securitisation Corporate Features Debt Capital Markets M&A